Clinical Study on Raman Spectra of Blood, Saliva and Urine in Patients With Cancer Treated by Modern Therapy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-10-01

Study Completion Date

2021-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Blood, saliva and urine samples of tumor patients on the day of admission and discharge were collected for Raman spectral analysis, which provided exploration for the prediction of efficacy, follow-up and prognosis according to the variation characteristics of Raman spectral.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Clinical Study of Modern Therapies on Flora in Body Fluids and Blood of Malignant Tumor Patients

NCT04202848

Lung Cancer Breast Cancer Gastrointestinal Cancer +1 more

UNKNOWN

Phase I/II Clinical Trial of LBL-015 for Injection

NCT05107011

Advanced Malignant Tumor

COMPLETED PHASE1/PHASE2

A Phase Ib Study of Primary Efficacy and Safety of IBI321 Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors

NCT05172856

Advanced Solid Tumors

UNKNOWN PHASE1

A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor

NCT04412564

Advanced Malignant Tumor

UNKNOWN PHASE2

A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage Small Cell Lung Cancer

NCT06267170

SCLC,Extensive Stage

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Blood, saliva and urine samples of tumor patients on the day of admission and discharge were collected for Raman spectral analysis, which provided exploration for the prediction of efficacy, follow-up and prognosis according to the variation characteristics of Raman spectral

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer Liver Cancer Stomach Cancer Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-80 years old;
* The patient whose tumor (tissue or cell) was first diagnosed by pathology;
* Plan to receive routine clinical treatment: chemotherapy, radiotherapy, surgery, intervention, targeted therapy, traditional Chinese medicine treatment and biological immunotherapy;
* Have relevant indications for treatment and have no contraindications;

Exclusion Criteria

* Severe or uncontrollable systemic diseases (such as unstable or uncompensated respiratory, heart, liver or kidney diseases, etc.);
* Other circumstances considered inappropriate by the researcher to participate in the study;

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No